CD209 and colorectal carcinoma: Other studies also reported a positive correlation between macrophages which expressed markers of M2 macrophages (e.g., CD163, DC-SIGN) or cancer-associated fibroblasts which expressed FSP1, FAP, and poor outcome for CRC patients22.